RxDoctor Payments Data

Hannah St Jeor

Nurse Practitioner · Rochester, MNNPI 1023598059

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.6% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Novo Nordisk at 40.5% of the total. Reporting peaked in 2023 at $1,683 and has fallen 81.1% since, to $318 in 2025. Among nurse practitioner clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,123in general payments, 2019–2025

Across 153 payments — averaging $20.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$633
  • Medtronic$221
  • Abbott$194
  • Amgen$133
  • Sanofi-aventis U.S. LLC$127
  • plus $550 from 12 others

What the payments were for

  • Food & beverage$3,111100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,123 in reported general payments places this provider in the 95th percentile of 3,021 nurse practitioner providers in Minnesota.

See all nurse practitioner providers in Minnesota

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide32$53,489
MounjaroTirzepatide20$36,509
Tresiba Flextouch U-100Insulin Degludec16$12,986
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$6,702
SynthroidLevothyroxine Sodium14$842
Levothyroxine Sodium75$721
Metformin Hcl37$401
Glimepiride18$290
Gabapentin18$287
Rosuvastatin Calcium13$250
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide14$235
Omeprazole20$228
Simvastatin20$207
Losartan Potassium16$205
Pravastatin Sodium14$175

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,264$53,48932 claims
Lilly USA, LLCMounjaro$633$36,50920 claims
AbbVieSynthroid$19$84214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,021 nurse practitioner providers in Minnesota.

Other nurse practitioner in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →